BiOptic and YD Biolabs have officially signed an MOU, combining BiOptic’s capillary electrophoresis platforms with YD Biolabs’ enzymatic nucleic acid labeling technology to establish Taiwan’s first fast, flexible, and fully localized nucleic acid modification and molecular diagnostics supply chain.
✨ Collaboration Highlights
• YD Biolabs’ enzymatic platform completes 5′-end labeling in under 3 hours, cutting turnaround time from 6–8 weeks to less than 1 week.
• BiOptic provides PCR and capillary electrophoresis systems to support quality validation and global market expansion.
• Together, we’re creating a one-stop workflow—from design → labeling → analysis.
🌱 Sustainable Production & Supply Chain ResilienceLocalized manufacturing reduces transportation emissions, while enzymatic chemistry aligns with ESG goals—enhancing the speed, flexibility, and autonomy of Taiwan’s molecular diagnostics ecosystem.
